Lance Wollenberg

4PUBLICATIONS
7CO-AUTHORS
Molecular targetsGene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Nov 11, 2025
An Evaluation of the Drug Interaction Potential of Encorafenib in Combination With Binimetinib Using the Inje Cocktail in Patients With Cancer.

Joseph Piscitelli, Micaela B Reddy, Lance Wollenberg

|Jan 31, 2025
The Absorption, Distribution, Metabolism, and Excretion of Binimetinib Following a Single Oral Dose of [<sup>14</sup>C]Binimetinib 45 mg in Healthy Male Participants.

Dustin Huynh, Erik Hahn, Micaela B Reddy

|Oct 14, 2023
Impact of posaconazole and diltiazem on pharmacokinetics of encorafenib, a BRAF V600 kinase inhibitor for melanoma and colorectal cancer with BRAF mutations.

Erik Hahn, Renae Chavira, Lance Wollenberg

|Sep 30, 2023
A phase I, single-center, open-label study to investigate the absorption, distribution, metabolism and excretion of encorafenib following a single oral dose of 100 mg [<sup>14</sup> C] encorafenib in healthy male subjects.

Lance Wollenberg, Erik Hahn, Jason Williams

Pageof 1

Frequent Collaborators

2 joint publications

Micaela B Reddy

1 joint publications

Erik Hahn

1 joint publications

Renae Chavira

1 joint publications

Joseph Piscitelli